This grant is for the purpose of advancing pediatric drug development by addressing critical research needs in the field. It aims to foster the creation and improve the acceptability of pediatric drug formulations tailored for different age groups. A significant emphasis is placed on encouraging the development of novel drug delivery systems specifically designed for the pediatric population. Investigators are strongly encouraged to explore innovative approaches and concepts new to pediatric formulation development. This includes the testing and utilization of cutting-edge techniques that offer superiority over existing methods, ultimately aiming to enhance the safety, effectiveness, and user-friendliness of medications for children. The overall goal is to improve therapeutic outcomes for pediatric patients.
Opportunity ID: 241775
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-344 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 04, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Small businesses Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Special district governments State governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education County governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development, testing and use of newly developed techniques superior to the ones currently used in the field. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-344.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.865 | FORMS-C | Forms-C | PKG00184692 | Sep 16, 2013 | May 07, 2016 | View |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222679 | May 16, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
241775 RR_SF424_2_0-2.0.pdf
241775 PHS398_ResearchPlan_2_0-2.0.pdf
241775 PHS398_CoverPageSupplement_2_0-2.0.pdf
241775 RR_KeyPersonExpanded_2_0-2.0.pdf
241775 RR_OtherProjectInfo_1_3-1.3.pdf
241775 PerformanceSite_2_0-2.0.pdf
Optional forms
241775 RR_SubawardBudget30_1_3-1.3.pdf
241775 PlannedReport-1.0.pdf
241775 PHS398_CumulativeInclusionReport-1.0.pdf
241775 PHS398_ModularBudget_1_2-1.2.pdf
241775 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
241775 RR_SF424_2_0-2.0.pdf
241775 PHS398_CoverPageSupplement_3_0-3.0.pdf
241775 RR_OtherProjectInfo_1_3-1.3.pdf
241775 PerformanceSite_2_0-2.0.pdf
241775 RR_KeyPersonExpanded_2_0-2.0.pdf
241775 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
241775 RR_Budget_1_3-1.3.pdf
241775 RR_SubawardBudget30_1_3-1.3.pdf
241775 PHS398_ModularBudget_1_2-1.2.pdf
241775 PHS_Inclusion_Enrollment_Report-1.0.pdf
241775 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
